This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Carboxymethyl Lysine (CML) ELISA Kit-Competitive
Product Overview
BioVenic General Carboxymethyl Lysine (CML) ELISA Kit-Competitive is designed for the quantitative determination of General Carboxymethyl Lysine (CML) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only.
Specifications
Target Information
N(6)-Carboxymethyllysine (CML) is an advanced glycation endproduct (AGE). CML is generated when the amino acid lysine reacts with reducing sugars (such as glucose or fructose). CML is associated with oxidative stress, inflammation, and age-related diseases. It accumulates in tissues and contributes to the pathogenesis of conditions like diabetes, atherosclerosis, and kidney disease. Researchers measure CML levels in biological samples (such as blood or urine) to assess glycation-related damage.
Shipping and Storage
This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.